Effect of coenzyme Q10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): Evaluation by noninvasive tissue oximetry
- 1 January 1999
- journal article
- case report
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 162 (1) , 65-68
- https://doi.org/10.1016/s0022-510x(98)00296-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Measurement of tissue oxygen consumption in patients with mitochondrial myopathy by noninvasive tissue oximetryNeurology, 1997
- MELASNeurology, 1996
- Recovery from exercise-induced desaturation in the quadriceps muscles of elite competitive rowersAmerican Journal of Physiology-Cell Physiology, 1992
- Strongly succinate dehydrogenase–reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke‐like episodesAnnals of Neurology, 1991
- Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)Acta Neurologica Scandinavica, 1991
- Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy.Proceedings of the National Academy of Sciences, 1989
- Long‐term coenzyme Q 10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiencyNeurology, 1989
- Treatment of Kearns‐Sayre syndrome with coenzyme Q 10Neurology, 1986
- Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q l0 in Kearns‐Sayre syndromeNeurology, 1985
- Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndromeAnnals of Neurology, 1984